Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Joan Marc Cabot"'
Publikováno v:
ADMET and DMPK, Vol 2, Iss 2, Pp 98-106 (2014)
In 1997 Valkó et al. developed a generic fast gradient HPLC method, based on the calculation of the chromatographic hydrophobicity index (CHI) from the gradient retention times, in order to measure lipophilicity. We have enhanced the correlations be
Externí odkaz:
https://doaj.org/article/7643fd29186d4cee94fd44ace1acb5aa
Publikováno v:
UPCommons. Portal del coneixement obert de la UPC
Universitat Politècnica de Catalunya (UPC)
Scopus-Elsevier
Universitat Politècnica de Catalunya (UPC)
Scopus-Elsevier
Herein, we present a proof-of-concept 3D (multilevel) passive microfluidic device for point-of-care applications including electrochemical biosensors. Multiphase flow (air-water interface) within multilevel microchannels has been evaluated using 3D n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3c470a47b31fe9e6c074f078d8723f97
https://hdl.handle.net/2117/330578
https://hdl.handle.net/2117/330578
Autor:
Nobutake Nakatani, Alexander Mosqueda, Joan Marc Cabot, Estrella Sanz Rodriguez, Kunio Yoshikawa, Brett Paull
Publikováno v:
ELECTROPHORESIS. 39
Autor:
Canyelles, Joan Marc Cabot, Capo, Jordi, Grynte, Ruta, Vicente, Elena Guerrero San, Jes��s-Valls, C��sar, Lux, Thorsten, Macias, Jose Gabriel, Masa, Marc, Martinez, Oscar
Liquid biopsy (LB) represents an important tool for modern oncology that enables increasingly safe, personalized, and robust cancer diagnosis and treatment. State-of-the-art LB systems require the amplification of the DNA in the blood samples, a cost
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2247d8f531230e9fae128c9ae62d1fb1
Autor:
Joan Marc Cabot Canyelles, Jordi Capo, Ruta Grynte, Elena Guerrero San Vicente, César Jesús-Valls, Thorsten Lux, Jose Gabriel Macias, Marc Masa, Oscar Martinez
Liquid biopsy (LB) represents an important tool for modern oncology that enables increasingly safe, personalized, and robust cancer diagnosis and treatment. State-of-the-art LB systems require the amplification of the DNA in the blood samples, a cost
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9406862fb1c19dd8127a1e3551bafc64